4051 Basel, ch
+41 (61) 20640-25
New data on renin inhibitor SPP100 (Rasilez) demonstrates its potential use in diabetic patients
Robust efficacy and safety data presented at European Society of Hypertension meeting
The use of information published here for personal information and editorial processing is generally free of charge. Please clarify any copyright issues with the stated publisher before further use. In the event of publication, please send a specimen copy to email@example.com.